000739 普洛药业
2024/03 - 三个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)3.84117.98718.71320.22220.021
总资产报酬率 ROA (%)1.8578.5159.39111.55511.653
投入资产回报率 ROIC (%)2.40810.81311.71714.86515.626

边际利润分析
销售毛利率 (%)24.04425.66423.90426.73027.959
营业利润率 (%)9.39010.6349.59312.51712.306
息税前利润/营业总收入 (%)9.2529.5898.59512.29813.042
净利润/营业总收入 (%)7.6219.1979.38110.68510.365

收益指标分析
经营活动净收益/利润总额(%)111.985103.197106.35891.46082.200
价值变动净收益/利润总额(%)-1.620-1.802-8.1625.99011.389
营业外收支净额/利润总额(%)-0.270-1.2870.044-0.474-0.890

偿债能力分析
流动比率 (X)1.3371.3271.2911.5301.698
速动比率 (X)1.0600.9960.9921.1991.323
资产负债率 (%)51.95451.20254.08844.0550.414
带息债务/全部投入资本 (%)35.67034.81740.54328.67318.206
股东权益/带息债务 (%)174.764181.084140.879243.917428.983
股东权益/负债合计 (%)92.36995.18984.771126.987141.447
利息保障倍数 (X)-81.691-10.542-8.570-76.92915.447

营运能力分析
应收账款周转天数 (天)52.48152.77153.18050.93648.181
存货周转天数 (天)73.26181.98868.45564.17565.930